Document reference

2020/2786(DEA)  
Inclusion of the new psychoactive substance N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of 'drug' (amend. the Annex to Council Framework Decision 2004/757/JHA)  
Basic information  

2020/2786(DEA)

DEA - Delegated acts procedure

Supplementing 2013/0304(COD)

Subject
4.20.03 Drug addiction, alcoholism, smoking
7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
02/09/2020
Non-legislative basic document published
C(2020)05897
09/09/2020
Initial period for examining delegated act 2 month(s)
16/09/2020
Committee referral announced in Parliament
17/11/2020
Delegated act not objected by Parliament
Technical information  
Procedure reference
2020/2786(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
LIBE/9/04106
Documentation gateway